arb

n.空气资源局

网络释义：血管紧张素受体拮抗剂(angiotensin receptor blocker)；血管紧张素受体阻滞剂；血管紧张素受体阻断剂

网络释义

n.1.空气资源局

1.血管紧张素受体拮抗剂(angiotensin receptor blocker)缓解蛋白尿、延缓GFR下降的效果，因此，建议aCEI和控制蛋白质摄人联合使用。血管紧张素受体拮抗剂(aRB)抗蛋白尿和抗 …

2.血管紧张素受体阻滞剂在目前血管紧张素受体阻滞剂（ARB）、钙通道阻滞剂（CCB）、血管紧张素转换酶抑制剂（ACEI）、利尿剂和β受体阻滞剂 …

3.血管紧张素受体阻断剂将血管紧张素受体阻断剂(ARB)坎地沙坦加到心力衰竭的标准治疗中，可以减少16%的心血管性死亡或充血性心力衰竭的住院危 …

4.血管收缩素受体阻断剂(Angiotensin Receptor Blockers)目前最新以血管收缩素受体阻断剂(ARB)为基础的二合一或三合一单锭复方降血压药，结合另一种或两种使用最广泛的降血压药 …

1.And ARBs are able to be used in coronary heart disease, fatal or not fatal.而且ARB适用于冠心病患者，无论是致命性还是非致命性的冠心病。

2.What do you think of the effects of ACEI or ARB drugs on insulin resistance and what are the possible mechanisms?您认为ACEI或ARB类药物对胰岛素抵抗有何作用，其可能的作用机制是什么？

3.In that analysis, all drugs, except ARBs , were significantly better than placebo or no treatment for reducing the risk of coronary events.在分析中，除了ARB类药物，所有抗高血压药物均较安慰剂或无治疗显著降低冠心病风险。

4.Objective To assess the effectiveness and safety of angiotensin II receptor antagonists(ARB) in treatment of portal hypertension.目的评价血管紧张素II受体拮抗剂（ARB）用于门静脉高压患者治疗的有效性和安全性。

5.What are the determinants making olmesartan the strongest anti-hypertensive ARB?使奥美沙坦成为最强效抗高血压ARB的决定因素是什么？

6.Thus , companies with poor prospects have seen shares rise and vice versa, undermining the logic of " stat arb " models .因此，前景不看好的企业股价上涨，而前景看好的企业反而股价下跌，这破坏了“统计套利基金”模型的逻辑。

7.In these patients, an ARB reduces the risk of death from a cardiovascular cause or hospital admission for worsening HF.在这些病人中，ARB可减少心源性猝死危险或心衰恶化而住院。

8.So what's the difference between olmesartan-based combination therapy and other ARBs-based combination therapy?基于奥美沙坦与基于其他ARB制剂的联合治疗相比有何不同？

9.Although the end point wasn't prespecified, heart-failure hospitalizations were significantly fewer among those getting ARB-based therapy.虽然终点并未预先设定，心衰竭住院在ARB为基础的治中更少。

10.Arbitration Rules of the Korean Commercial Arb.韩国商事仲裁院仲裁规则。